Xencor, Inc. (XNCR)
PHARMACEUTICAL PREPARATIONS
Xencor, Inc. (XNCR) is listed on Nasdaq, where it has traded since December 3, 2013.
- Listed On
- Nasdaq
- Listed Since
- December 3, 2013
- Employees
- 260
- Market Cap
- $2.2B
About Xencor, Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 202 institutions reported holding XNCR, with 84.2 million shares worth $1.4 billion in aggregate. The largest reported holder was BlackRock, with 13.7 million shares worth $219.8 million. Of the 5 largest holders listed below, 1 added shares, 2 reduced their positions and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 13,651,261 | $220M | Added 4.72% |
| Primecap Management Co | 10,181,322 | $164M | Reduced 1.52% |
| Bvf Inc/IL | 7,133,720 | $115M | Unchanged |
| Rtw Investments | 6,777,461 | $109M | Unchanged |
| Vanguard | 6,055,460 | $97M | Reduced 15.27% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is XNCR?
Xencor, Inc. (XNCR) is listed on Nasdaq, where it has traded since December 3, 2013.
Who are the largest institutional holders of XNCR?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of XNCR were BlackRock, Primecap Management Co and Bvf Inc/IL.
How many institutions own XNCR?
202 institutions reported a position in XNCR for the quarter ended June 30, 2026, worth $1.4 billion in total.
Did institutions buy or sell XNCR last quarter?
Of the 5 largest reported holders, 1 added shares, 2 reduced their positions and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for XNCR.
Every reported institutional holder, plus insider and congressional trades in XNCR, on SentiSense.